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Accepted 26 June 2015In addition to their fermentable dietary fiber and the soluble β-glucan fiber, oats have unique
avenanthramides that have anti-inflammatory and antioxidant properties that reduce
coronary heart disease in human clinical trials. We hypothesized that oat consumption will
increase insulin sensitivity, reduce body fat, and improve health span in Caenorhabditis elegans
through amechanism involving the daf-2 gene, which codes for the insulin/insulin-like growth
factor-1–like receptor, and that hyperglycemia will attenuate these changes. Caenorhabditis
eleganswild type (N2) and the null strains sir-2.1, daf-16, and daf-16/daf-2were fed Escherichia coli
(OP50) and oat flakes (0.5%, 1.0%, or 3%) with and without 2% glucose. Oat feeding decreased
intestinal fat deposition in N2, daf-16, or daf-16/daf-2 strains (P < .05); and glucose did not affect
intestinal fat deposition response. The N2, daf-16, or sir-2.1 mutant increased the pharyngeal
pumping rate (P < .05), a surrogate marker of life span, following oat consumption. Oat
consumption increased ckr-1, gcy-8, cpt-1, and cpt-2mRNA expression in both theN2 and the sir-
2.1mutant, with significantly higher expression in sir-2.1 than in N2 (P < .01). Additional glucose
further increased expression 1.5-fold of the 4 genes in N2 (P < .01), decreased the expression of
all except cpt-1 in the daf-16mutant, and reducedmRNA expression of the 4 genes in the daf-16/
daf-2 mutant (P < .01). These data suggest that oat consumption reduced fat storage and
increased ckr-1, gcy-8, cpt-1, or cpt-2 through the sir-2.1 genetic pathway. Oat consumption may
be a beneficial dietary intervention for reducing fat accumulation, augmentinghealth span, and
improving hyperglycemia-impaired lipid metabolism.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Modern lifestyle-related chronic diseases, such as obesity,
insulin resistance, and type 2 diabetes mellitus, are major
health challenges of the 21st century [1]. Changes in dietary
habits and lifestyle are among the primary causes for this
undesirable development, which is already being seen in the
younger population.
An inverse connection of longevity and fat mass is charac-
teristic of humans above 25% ± 5% body fat when accompanied
by obesity-related disease [2]. Both obesity and aging decrease
insulin sensitivity, impair the immune response, increase
inflammation, weaken the gut-bloodstream barrier, and de-
crease physical mobility [2]. Promotion of dietary intervention,
exercise, and lifestyle modification, including second-line obe-
sity treatments, to sustain weight loss has been elusive [3,4].
Even thoughadirect relationship between calorie restriction and
health span has been observed in animal models [5,6], control-
ling food intake in humans is difficult, mainly transient, and
often unsustainable because it involves multiple factors includ-
ing psychological factors.
Caenorhabditis elegans is well suited to obesity studies. Lipid
oxidation pathways are present in the C elegans model,
such as cluster differentiation transport protein, carnitine
palmitoyltranferase–1, acetyl coenzyme A carboxylase, and
acetyl CoA synthetase. Resistant starch and short-chain fatty
acids reduce intestinal fat deposition (IFD) in C elegans,
demonstrating that themodel can be used to evaluate bioactive
components from gut fermentation [7–9]. Caenorhabditis elegans
is a small, free-living soil nematode, a multicellular eukaryotic
organism, distributed widely around the world. Caenorhabditis
elegans is the first animal to have its genome completely
sequenced and conserves 65% of the genes associated with
human disease [8]. Caenorhabditis elegans deposits fat for energy
storage along its intestinal tract of its transparent body [10].
Thus, lipid-staining dyes such as Nile red can be visualized
directly and quantitated photometrically in the intact C elegans
[11]. Food intake and transport in C elegans are regulated by
pharyngeal movements and relaxation in the terminal bulb of
the pharynx. The pharyngeal pumping rate (PPR) declines with
age because of sarcopenia, and PPR is a surrogate marker of
aging [12].
Many dietary interventions with enriched nondigestible but
fermentable carbohydrates may reinforce optimal nutrition,Table 1 – Information on C elegans strains
Strains Gene
deficient
Human homologs F
Wild type (N2) – – –
daf-16(mgDf50)I daf-16 Forkhead box protein O (FOXO) C
r
p
daf-16(mgDf50)I;
daf-2(m65)III
daf-16
and daf-2
FOXO and insulin/IGF-1 receptor T
m
l
sir-2.1(ok434)IV sir-2.1 NAD-dependent protein deacetylase
sirtuin-1
T
t
renhance physiological function, reduce obesity, improve me-
tabolic dysfunction, limit disease [4], and produce anticancer
effects in humans [13,14]. The mechanisms of these interven-
tions have been reported to be due to increased mRNA
expression of the GLP-1 precursor, proglucagon and peptide
YY in rodents [15], improved glucose tolerance [16,17], in-
creased phase I xenobiotic metabolizing enzymes that are a
hallmark of long-lived mice [18], promotion of mitochondrial
fatty acid oxidation, and increased energy expenditure in
Drosophila or adult rodents at ages analogous to 56 to 65 years
in humans [17,19,20]. Consequently, fermentable dietary fiber
reduces body fat accumulation [19,21], plasma cholesterol
and triglycerides [22], and insulin resistance [23] in rodents
and humans.
In addition to resistant starch, oats (Avena sativa) contain
the soluble fermentable dietary β-glucan fiber and the unique
phytoalexins avenanthramides (avns). Avenanthramides pro-
vide safe, antioxidant, anti-inflammatory, and antiangiogenic
properties [24–26]. Consuming oats introduces a hypocaloric
intervention through caloric dilution [27,28]; reduces low-
density lipoprotein cholesterol [29], body fat [30], and coro-
nary heart disease risk factors in human clinical trials [31,32];
increases fasting peptide YY, GLP-1, postmeal satiety, and
insulin sensitivity [33]; and elevates endothelium nitric oxide
production [34,35]. Like resistant starch, β-glucans are ferment-
able dietary fibers resistant to digestion and high-temperature
cooking. An associationwas detected between total fermentable
phenolics, a reduction in triacylglycerols, and fewer aorta
inflammatory lesions in mice [36].
Decreased daf-2 signaling, the only homolog of the human
insulin and insulin-like growth factor (IGF) receptor gene in
C elegans, increases C elegans’ life span in a DAF-16/FOXO–
dependent manner [37–39], which is reversed by hyperglyce-
mia [40]. Furthermore, doubling the C elegans sir-2.1 gene
number increases life span by 50% in a daf-16–dependent
manner [41,42]. We hypothesized that oat consumption
would reduce IFD, improve insulin resistance created by
added glucose (2%) to the C elegans feeding media, improve
hyperglycemia-impaired lipid metabolism, and increase
health span through daf-16 and/or sir-2.1 pathway(s). A
number of genes in C elegans have been proven to promote
fat storage and mediate satiety, for example, guanylyl
cyclases and the cholecystokinin (CCK) receptor. The objec-
tives of this study were to quantify IFD by the fluorescenceunctions References
[7,59]
aenorhabditis elegans daf-16 has a central
ole in mediating the downstream insulin signaling
athways and is the major target of the daf-2 pathway.
[8]
he C elegans daf-2 gene encodes the homolog of the
ammalian insulin receptor, which has preserved
igand-binding and tyrosine kinase domains
[8]
he sir-2.1 transgene functions upstream of daf-16 in
he insulin-like signaling pathway;
egulates lifespan independently.
[42]
Table 2 – Composition of oats (Quaker® Oats)
Content Quantity (%) Content Quantity (ppm)
β-Glucan 4.6 Ave 2c 5.4
Insoluble dietary fiber 7.3 Ave 2f 8.8
Starch 60.9 Ave 2p 5.3
Protein 13 Ave 5p 1.2
Lipids 6.6 Ave total 20.8
Moisture 10.3
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counting PPR, and to determine the genetic pathway(s) using
daf-16– and/or sir-2.1–deficient mutants.2. Methods and materials
Caenorhabditis elegans strains and their standard laboratory
food source Escherichia coli (OP50, uracil auxotroph) were
obtained from the Caenorhabditis Genetics Center (University
of Minnesota, Minneapolis, MN). The C elegansmodel does not
require Institutional Animal Care and Use Committees regula-
tion or approval [43].
2.1. Culture of E coli (OP50)
OP50 were cultured by the standard method described
elsewhere [7]. Briefly, approximately 10 μL of stock E coli
solution was added to media and incubated at 37°C for 24
hours. The OP50 were then subcultured in Petrifilm (3M
Corporate, St Paul, MN) at 37°C for 24 hours, the colonies
were confirmed to be at a density of 5 × 108 to 5 × 1011 cfu/mL,
and the C elegans were allowed to eat ad libitum.
2.2. Culture of C elegans
Caenorhabditis elegans wild type (N2) and null mutants sir-
2.1(ok434)IV, daf-16(mgDf50)I, and daf-16(mgDf50)I;daf-2(m65)III
were used in this study (Table 1). They were grown on
Nematode Growth Media agar plates (∅35 mm) and stored
in a low-temperature incubator (Revco Tech, Nashville, NC) at
20°C or 15°C (daf-16(mgDf50)I;daf-2(m65)III). Caenorhabditis elegans
were age synchronized.Mature gravid C eleganswere transferred
individually onto the agar plates and treated with a NaOH
(1 mol/L) and sodium hypochlorite solution (5.25%, 5:2 ratio) to
dissolve the body and release viable eggs [7]. One day before the
experiment, 200 μL of a feeding media containing E coli was
added to the agar dish.Table 3 – Protocol of experiment
Dosage (%)
Treatments Without glucose With glucose
(50 μL) 0 0.5 1 3 0 0.5 1 3
OP50 (2 × 109 cfu/mL, μL) 10 10 10 10 10 10 10 10
Oats (5%, μL) 0 5 10 30 0 5 10 30
Glucose (50%, μL) 0 0 0 0 2 2 2 22.3. Diet composition
Oats (Quaker Oats instant flakes, PepsiCo Inc, Chicago, IL) (Table 2)
were powdered using a centrifugal mill with a 0.75-mm sieve (ZM
200; Retsch, Haan, Germany), autoclaved at 121°C, and suspended
in distilled deionized water (5% w/v).
Control C eleganswere fed with OP50 only. The experimen-
tal groups were fed OP50 supplemented with 0.5%, 1.0%, or
3.0% oats at the larval stage L2 (Table 3). Two percent glucose
was added to an additional group of each strain with the oats.
The dietary nutrient composition is listed in Table 4 [44].
Caenorhabditis elegans were transferred to fresh dishes every
other day receiving treatment (50 μL).
2.4. Pharyngeal movement (PPR)
Caenorhabditis elegans were examined periodically using a
stereomicroscope (SMZ1500; Nikon, Melville, NY) with trans-
mitted light. The PPR was recorded manually by independent
observers then were returned to the incubators [9,45].
2.5. Fluorescence microscopy
Lipophilic dye Nile red was used to stain for IFD [7]. S-basal
solution was added to the dish to wash the C elegans. The
solution containing the C elegans was centrifuged for 20
seconds at 805g, and this procedure was repeated twice.
Caenorhabditis elegans were then fixed with 4% paraformalde-
hyde over 2 hours at 4°C and washed with phosphate-
buffered saline for 5 minutes × 3. Nile red (50 μL) was applied
to the specimens for 10minutes. Tenmicroliters of Fluoromount-
G (Southern Biotechnology Associates, Birmingham, AL) was
applied to a glass slide followed by 20 μL of the medium
containingNile red–stainedC elegans. A cover glasswasmounted
on the glass slide, and the slides were viewed with an
epifluorescence microscope (Nikon Eclipse, Ti) equipped with a
Texas red filter. Fluorescent micrographs were taken with a
digital camera (Andor, DU-885k) andwere analyzed using Nikon-
Elements (version 3.22.11). Optical densities (arbitrary units, % of
control) of Nile red–labeled IFD were determined for adult
C elegans (larvae stage 4).
2.6. Quantitative real-time reverse transcription
polymerase chain reaction reagents
Trizol reagent (T9424), chloroform (C2432), and isopropanol
(I9516) were purchased from Sigma-Aldrich (St Louis, MO).
Taqman PCR core kit (N8080228), MuLV Reverse Transcriptase
(N8080018), and Ribonuclease (RNase) Inhibitor (N8080119)
were obtained from Life Technologies (Grand Island, NY).
RNase free micro tubes and pipette tips were used in RNA
isolation and quantitative real-time reverse transcription
polymerase chain reaction (Q-RT-PCR).
2.7. RNA isolation
Total RNA was extracted using the Trizol reagent as described
elsewhere [23]. Caenorhabditis elegans samples were homoge-
nized in 1 mL Trizol reagent per 50 to 100 mg of tissue.
Samples went through 5 freeze-thaw cycles in which they
Table 4 – Diet ingredient composition
Nutrients Oat diet
(mg/mL)
OP50
(mg/mL)
Oat treatment (mg/plate)
0 0.5% 1% 3%
β-Glucan 0.046 – 0.000 0.012 0.023 0.069
Insoluble
dietary fiber
0.073 – 0.000 0.018 0.037 0.110
carbohydrate 0.609 7.5 0.375 0.527 0.680 1.289
Protein 0.130 37.5 1.875 1.908 1.940 2.070
Lipids 0.066 5.0 0.250 0.267 0.283 0.349
ig. 1 – Nile Red staining of the IFD in C elegans after oat
eding in the absence or presence of 2% glucose.
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bath. The homogenized samples were vortexed at room
temperature to allow the complete dissociation of nucleopro-
tein complexes. Two hundred microliters of cold pure
chloroform was added, and the samples were vortexed for
15 seconds and incubated at room temperature for 5 minutes.
The samples were centrifuged at 15,616g for 10 minutes at
4°C, and the top aqueous phase was transferred to a fresh
tube. A 600-μL cold isopropanol was used for the initial
homogenization; and the samples were incubated at room
temperature for 10 minutes, vortexed for 15 seconds, and
centrifuged at 15,616g for 10 minutes at 4°C. The supernatant
was removed, and the RNA pellet was washed once with 1 mL
of cold 75% ethanol. The sample was vortexed and centri-
fuged at 6100g for 5 minutes at 4°C. The supernatant was
removed completely, and the RNA pellet was briefly air-dried.
The RNA pellet was resuspended in 0.1% diethyl pyrocarbonate–
treated water and stored at −80°C. The RNA concentration
was analyzed with a Nanodrop ND-1000 spectrophotometer
(Wilmington, DE).
2.8. Quantitative RT-PCR
The mRNA levels of ckr-1, gcy-8, cpt-1, and cpt-2 were
determined using Taqman Q-RT-PCR. The following compo-
nents were added in 1-step RT-PCR: 2.2 μL H2O, 1 μL 10×
Taqman buffer A, 2.2 μL 25 mmol/L MgCl2 solution, 0.3 μL 10
mmol/L dATP, 0.3 μL 10 mmol/L dCTP, 0.3 μL 10 mmol/L dGTP,
0.3 μL 10 mmol/L dUTP, 0.05 μL 20 U/μL RNase inhibitor,
0.05 μL 50 U/μL MuLV reverse transcriptase, 0.05 μL 5 U/μL
Amplitaq gold, 0.25 μL Taqman probe and primers, and 3 μL
5 ng/μL RNA. The PCR was conducted in triplicate using a
Taqman probe and primer set (Life Technologies, Grand
Island, NY) for cholecystokinin receptor homolog (ckr-1,
Ce02408606_m1), guanylyl cyclase–8 (gcy-8, Ce02456184_g1),
carnitine palmitoyltranferase–1 (cpt-1, Ce02440434_m1), and
carnitine palmitoyltranferase–2 (cpt-2, Ce02459919_g1). The
mRNA signal was normalized over a eukaryotic 18S rRNA
(Hs99999901-s1) internal control. The reaction was conducted
using a 7900 HT Fast real-time PCR system (Life Technologies).
Reverse transcription was added at 48°C for 30 minutes, and
AmpliTaq gold activation (denaturation) was performed at
95°C for 10 minutes. Amplification of the DNA involved 40
cycles of 15 seconds at 95°C and 1 minute at 60°C. Data were
analyzedusing the SequenceDetector Software (LifeTechnologies,
Carlsbad, CA). The relative quantification of gene expression
(2−ΔΔCt) was calculated.F
fe2.9. Statistical analyses
All data were presented as means ± SEM. Student t tests
and analysis of variance were used for IFD, and analysis of
covariance was used to compare the slopes of PPR data (SAS 9.4,
Cary, NC). Statistical significance was set at P ≤ .05. Principle
component analysis (PCA) was performed to cluster the factors
of the oats results (SAS 9.4). Power analyses were performed to
predict the sample size to achieve 80% power for PPR (minimum
n = 7) and IFD (n = 5) with statistical significance as .05.3. Results
3.1. Intestinal fat deposition
Oat feeding reduced IFD by 30% (0.5% and 1.0%) in the N2
strain (P < .05), and the addition of glucose to the oats
increased IFD. Intestinal fat deposition decreased by 17% in
response to 0.5% oats and 37% in response to 1.0% oats in the
daf-16(mgDf50)I and increased with glucose treatment com-
pared with the group that did not receive glucose (P < .05).
The daf-16(mgDf50)I;daf-2(m65)III showed a similar dose-
dependent reduction in IFD in response to oat feeding as
well as in the presence of glucose (P < .05). Intestinal fat
Fig. 2 – Oat feeding affected PPR, a surrogate marker of life span in C elegans.
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consumption in the sir-2.1(ok434)IV (P > .05) (Fig. 1).
3.2. Pharyngeal pumping rate
The PPRs declined in all groups as the C elegans aged. The oat
treatment (0.5%, 1.0%, or 3%) increased the PPR in N2, daf-16,
and sir-2.1mutants (n = 24 C elegans/3 dishes, P < .001-.05). The
PPR in N2 was increased in the oat group (0.5%, 1.0%, or 3%) in
the presence of glucose (P < .005-.03). This increase persisted
in the presence of glucose at a low dose in daf-16 or daf-16/daf-
2 mutant (P < .05) (Fig. 2).3.3. Lipid metabolism gene expression
Oat feeding (0.5% and 1%) increased the mRNA expression of ckr-1,
gcy-8, cpt-1, and cpt-2 in the C elegans N2, and sir-2.1– and daf-16–
deficient strains (P < .01). Additional glucose further increased these
mRNA expressions in N2 and sir-2.1. In the daf-16–deficient strain,
ckr-1 and gcy-8were increased after oat feeding (P < .01). All 4 genes
testedwereelevated inresponse toglucose treatmentalone, andoat
consumption in thepresenceofglucosesignificantly reducedmRNA
expression of the 4 genes (P < .01). Oat feedingwith glucose reduced
mRNA expression of all 4 genes in daf-16/daf-2–deficient strains (P <
.01). Oats (0.5%) plus glucose increased cpt-1 and cpt-2 (P < .01, Fig. 3).
Fig. 3 – Oat feeding altered gene expression of ckr-1, gcy-8,
cpt-1, and cpt-2 by Q-RT-PCR in C elegans.
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Principle component analyses revealed 2 theoretical strong
factors that played important roles in the relationship of the
components that were tested in this study (Fig. 4, Table 5).
Inverse relationship between the IFD and the PPR was
detected in N2, daf-16/daf-2, and sir-2.1 mutants. The PPRs
were strongly and positively related to the 2 factors in the 3
strains. By contrast, the IFDs were strongly and positively
related to the factor 1 in the N2 and the daf-16/daf-2 double
mutant, which was negatively associated in the sir-2.1
mutant. The IFD or PPR seemed weakly related to the ckr-1,
cpt-1, cpt-2, and gcy-8. The ckr-1, cpt-1, cpt-2, and gcy-8 hadstrong positive relationships with factor 1 N2, daf-16/daf-2,
and sir-2.1 mutants. A loose but positive relationship of the 4
genes with the factor 2 was seen in the daf-16 mutant,
whereas the IFD was negatively related to the factor 1 and the
PPR did not have any association with either the factors or the
4 genes.4. Discussion
The effect of oat consumption pairedwith orwithout 2% glucose
was evaluated in theC elegansmodel byobserving changes in IFD
determinedby the fluorescent intensity ofNile red, alterations in
health span indicated by PPR, and variations in selected mRNA
expression indicated by PCR in this study. The IFD was reduced
in N2, and the daf-16– and daf-16/daf-2–deficient mutants. Apart
from natural age-related decline of the PPR in all groups, oat
treatment sustained the PPR in N2 with or without glucose. Oat
treatment also sustained the PPR in daf-16 and sir-2.1 mutants
without glucose. Low-dose oat treatment (0.5%) increased the
PPR in the presence of glucose. Oat consumption increased
mRNA expressions of ckr-1, gcy-8, cpt-1, and cpt-2 genes, which
were greater in N2 than in the sir-2.1 mutant; and additional
glucose further increased the expression by 1.5-fold in both
strains. The effects of oats on health span and IFD in N2 was
mediated by daf-2 and partially depended on daf-16, with and
without the presence of hyperglycemia.
Hyperglycemia often coexists with hyperlipidemia. In
C elegans, inactivation of more than 300 genes has been
shown to reduce IFD; and inactivation ofmore than 100 genes,
to increase fat storage [46]. Oat consumption significantly
reduced IFD in the N2, and daf-16– and daf-16/daf-2–deficient
mutants, whereas the presence of glucose increased IFD.
However, oats reduced IFD even when there was insulin
resistance, as seen in the daf-16/daf-2–deficient group and
other groups with additional glucose. Glucose did not
attenuate the oat-induced IFD reduction in the daf-16/daf-2–
deficient mutant, suggesting an indirect improvement in
insulin sensitivity through lipid metabolism activating other
pathway(s), such as the serotonin pathway. In rodent
diabetes, hyperglycemia is associated with an increase in
peroxisome proliferator activator alpha (PPARα) activity
associated with insulin resistance [10]. In a C elegans model,
deletion of the nuclear hormone receptor–49, a homologue of
PPARα, prevents hyperlipidemia and restores insulin sensi-
tivity in a manner similar to PPARα-null mice [47]. The
reduced IFD following oat consumption in the daf-16/daf-2–
deficient mutant suggests that oatsmay improve hyperglycemia-
impaired lipid metabolism.
Reduced food intake, reduced lipid metabolism, and a
reduction in metabolic turnover in N2 are associated with an
extension of life span [41]. Unlike the N2, or daf-16/daf-2– and
daf-16–deficient mutants, the IFD was only mildly reduced by
the same amount of oat consumption in the sir-2.1–deficient
mutant with increased mRNA expression of the 4 genes
similar to N2, suggesting increased lipid metabolism. The
ability of both the wild-type and mutant nematodes to
sustain the PPR indicates that oat consumption improved
health span independent of the sir-2.1 pathway, which relates
to the co-regulator/genes in the aging process in C elegans
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Fig. 4 – Scatter plot of PCA showing the 2 strong factors in relationship with ckr-1, cpt-1, cpt-2, gcy-8, PPR slope, and IFD.
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shows that involvement of sir-2.1 in lipid metabolism has
multiple factors similar to life span [41], and either a higher
dose is required in the absence of the sir-2.1 gene pathway
or the sir-2.1 pathway was not critically involved in the
IFD reduction.Table 5 – PCA description: factor 1 and factor 2
Relation to factors Factor 1
PPR IFD ckr-1 gcy-8 cpt
N2 11 24 99 98 100
daf-16(mgDf50)I −20 −15 95 98 29
daf-16(mgDf50)I;daf-2(m65)III −24 64 93 87 90
sir-2.1(ok434)IV −17 −34 98 78 96Hyperglycemia reduced the C elegans life span [50] and
completely suppressed the long life span of daf-2(−) insulin/
IGF-1 receptor mutants in C elegans [4]. The daf-16 gene plays a
central role in activating the downstream insulin signaling
pathways and is the major target of the daf-2 that negatively
regulates daf-16 [50,51]. In the present study, oat feedingFactor 2
-1 cpt-2 PPR IFD ckr-1 gcy-8 cpt-1 cpt-2
100 94 −90 1 15 2 −6
64 2 77 20 7 93 73
99 93 −73 29 30 9 8
98 95 −89 −3 52 24 −7
841N U T R I T I O N R E S E A R C H 3 5 ( 2 0 1 5 ) 8 3 4 – 8 4 3increased PPR and decreased IFD, which weremediated by the
daf-16/daf-2 pathways. The benefit fromoats’may be attributed
to its being high in fibers, β-glucan, proteins, and unique avns.
Although activation of the CCK receptor does not change
circulating triacylglycerol or adipose tissue, it increases
glucose tolerance and insulin sensitivity and decreases liver
triacylglycerol in mice [52,53]. Similarly, in humans, activa-
tion of CCK pathway does not appear to play a central role in
long-term energy balance but signals postprandial satiety
[53,54]. However, ckr-1, the analogous gene in the C elegans
species, increased in response tooat consumption that decreased
IFD in the presence of glucose andpreserved PPR, suggesting that
ckr-1 has a potential role in the lipid metabolism. The gcy-8
is exclusively expressed in AFD neurons and contributes to
thermotaxic behavior [55]. Increased expression of gcy-8 may
indicate an increase in metabolic rate. In the daf-16–deficient
mutant, themRNAexpression of ckr-1 and gcy-8was increased in
response to oat feeding. This effect was reversed in presence
of glucose that initially elevated cpt-1 and cpt-2 followed by a
reduction when oats were added.
An elevated cpt-1 or cpt-2 suggests an augmented lipid
β-oxidation and turnover. Expression of all 4 genes was
reduced in the daf-16/daf-2–deficient mutant when treated
with oats, and cpt-1 and cpt-2 expression increased nearly
2-fold with additional glucose. The reduced cpt-1 or cpt-2 in daf-
16/daf-2–deficientmutant suggests that the C eleganswere either
unable to use/metabolize the nutrients from the food as seen in
daf-16–deficient mutant or were unable to adequately downreg-
ulatemetabolic turnover as observed in the daf-16/daf-2–deficient
mutant, thus reducing IFD. In the 3 strains, N2, daf-16/daf-2, and
sir-2.1 mutants, the factor 2 of the PCA was closely related to
health span, which is inversely related to IFD; and the factor 1
had strong positive relationships with cpt-2 and gcy-8. The PCA
data showedan inverse relationship of the daf-16 to the IFD, cpt-1,
and cpt-2.
The exclusive and unique avns in oats are fermentable
polyphenols that also resist digestion and provide health benefits.
A high β-glucan concentration increases viscosity in the gastroin-
testinal tract, delays nutrient absorption, decreases the glycemic
peak by 50%, lowers low-density lipoprotein cholesterol, reduces
body fat in humans and rodents [56], counteracts obesity-related
inflammation [25], and enhances immunity in C elegans by
activating the dectin-1 receptor and DAF-2/insulin-like receptor
pathways [57,58]. These avns, along with the β-glucan content of
oats, make oats a unique food that may aid in lowering body fat
and controlling body weight. Future studies will investigate
possible synergistic effects of avns and β-glucan, as well as the
role of the serotonin pathway in improving hyperglycemia-
induced hyperlipidemia and increasing health span.
This study had limitations aswell.Caenorhabditis eleganshave
two-thirds of genes that are related to human diseases. Thus,
C elegans is used as a stage for use in high-throughput screening
to search for nutritional interventions for health before confir-
matory studies in higher animal models and human clinical
trials. Compensatory pathways that exist in higher animalsmay
be not discovered by the present study using C elegans. Active
components of the oats extract will be further tested in follow-
up studies using higher animal species.
In conclusion, our data indicate that oats have unique
properties that induce an improvement in insulin sensitivity,reduce IFD, and extend health span in the C elegans model
organism, giving support to our study hypothesis. As part of a
healthy diet, oats are an appropriate food to improve public
health. Avenanthramides and β-glucan are functional food
components of oats that can be incorporated into the daily
diet in various ways. Caenorhabditis elegans is an attractive in
vivo animal model for initial studies of nutrition interven-
tions before confirmation in higher animal species.Conflict of interest statement
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